Case Report
===========

The patient is a 52-year-old female, height 160 cm, who was referred for heart failure. Her history included recurrent syncopes/seizures in childhood, pyelonephritis in adolescence, diabetes, arterial hypertension, hyperCKemia, coronary heart disease, atrial flutter requiring cardioversion, ablation, and anticoagulation, non-ST segment myocardial infarction, hyperlipidemia, statin myopathy, and smoking 35 pack/years. The family history was positive for dementia and statin myopathy (mother).

Upon bisoprolol, eplerenone, sacubitril/valsartan, and furosemide, heart failure resolved. Creatine-kinase did not exceed 899U/L ( *n* \< 170U/L). Electrocardiogram showed left-anterior hemiblock and right bundle-branch block. Echocardiography revealed systolic and diastolic dysfunction, ventricular hypertrophy, biatrial enlargement, right ventricular dilatation, and noncompaction. Cardiac magnetic resonance imaging confirmed echocardiographic findings and additionally revealed transmural late gadolinium-enhancement. For primary prophylaxis, an implantable cardioverter-defibrillator (ICD) was implanted. ICD-implantation was complicated by a toxic reaction to local anesthetics. Nonalcoholic liver cirrhosis was detected.

On hospital day (hd) 17, she developed acute, muscular respiratory failure under continuous positive airway pressure-assisted spontaneous breathing (CPAP-ASB) requiring intubation/mechanical ventilation. Clinical neurologic exam revealed hypermetropia, weakness for head anteflexion (M5-), weakness for elbow extension (M5-), reduced tendon reflexes, and male hair-type. Nerve-conduction studies revealed axonal neuropathy. Muscle biopsy revealed selective type-2 fiber atrophy, occasional COX-negative fibers, and deposition of complement complexes. Genetic panel for myopathy, neuropathy, and cardiomyopathy revealed the variants c.115G\>C and c.1327G\>T of unknown significance in *HNRNPDL* and *SETX* , respectively.

Extubation was unsuccessful two times and followed by a third intubation on hd 33 and tracheotomy. On hd 110, the patient was released with noninvasive ventilation (NIV) by a home-respirator. After a period of altogether 10 months, she could be weaned off NIV.

Despite a panel for myopathy, neuropathy, and cardiomyopathy, the cause of cardiomyopathy and primary myopathy could not be identified. *HNRNPDL* variants have been associated with autosomal-dominant limb girdle muscular dystrophy-1G and *SETX* variants have been associated with familial amyotrophic lateral sclerosis. However, the clinical presentation was neither compatible with limb girdle muscular dystrophy-1G [@JR_1] nor with familial amyotrophic lateral sclerosis. [@JR_2] Arguments in favor of a metabolic myopathy are previous reports about acute respiratory failure as a complication of metabolic myopathy, [@JR_3] [@JR_4] the multisystem disease, the mother's history positive for statin-induced myopathy and dementia, deterioration of muscle weakness upon local anesthestics, statin-intolerance, noncompaction, and incompatibility of the variants with the patient's phenotype. Recovery from muscular respiratory failure may be attributed to ventilatory treatment and care, [@JR_5] heart failure therapy, exemplary compliance, or the reversible nature of muscle weakness.

This case shows that acute muscular respiratory failure may require traditional diagnostic work-up and long-term invasive/noninvasive ventilation, and that panel investigations not necessarily lead to a conclusive diagnosis.
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